Supernus Pharmaceuticals, Inc. (SUPN)
51.65
+2.28
(+4.62%)
USD |
NASDAQ |
Feb 06, 16:00
51.64
-0.02
(-0.03%)
After-Hours: 20:00
Supernus Pharmaceuticals SG&A Expense (TTM) : 442.58M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.434B |
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Vertex Pharmaceuticals, Inc. | 1.644B |
| Krystal Biotech, Inc. | 136.75M |
| Moderna, Inc. | 1.061B |